| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Timothy Hayes is Director at HIT. Timothy Hayes's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $78K at current prices.
The HIT filings lean toward selling, a net 29,730 shares.
Timothy Hayes has 7 Form 4 filings on record from June 2025 to October 2026, all as Director at Health In Tech (HIT), 2025–2026.
The 9 reported transactions were 5 stock awards, 3 open-market sales and 1 disposition back to the company.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $27K.
The largest open-market sale was 17,730 shares of HIT at an average $0.92 on September 11, 2026, about $16K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.